Acutus Medical, Inc. (AFIB)
USD 0.04
(-1.64%)
USD 0.04
(-1.64%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.22 Million USD | -85.19% |
| 2022 | 75.8 Million USD | -24.35% |
| 2021 | 100.2 Million USD | 19.56% |
| 2020 | 83.81 Million USD | 29.19% |
| 2019 | 64.87 Million USD | 100.19% |
| 2018 | 32.4 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.22 Million USD | -119.3% |
| 2024 Q1 | 3.33 Million USD | 112.62% |
| 2023 Q1 | 15.68 Million USD | -0.22% |
| 2023 FY | 11.22 Million USD | -85.19% |
| 2023 Q3 | 12.22 Million USD | -23.98% |
| 2023 Q2 | 16.08 Million USD | 2.56% |
| 2023 Q4 | -26.44 Million USD | -316.28% |
| 2022 Q3 | 15.62 Million USD | -29.23% |
| 2022 Q2 | 22.07 Million USD | -1.38% |
| 2022 Q1 | 22.38 Million USD | -9.38% |
| 2022 FY | 75.8 Million USD | -24.35% |
| 2022 Q4 | 15.71 Million USD | 0.58% |
| 2021 FY | 100.2 Million USD | 19.56% |
| 2021 Q3 | 25.1 Million USD | 1.33% |
| 2021 Q4 | 24.7 Million USD | -1.59% |
| 2021 Q2 | 24.77 Million USD | -3.31% |
| 2021 Q1 | 25.62 Million USD | 6.2% |
| 2020 Q3 | 24.17 Million USD | 39.74% |
| 2020 Q2 | 17.3 Million USD | -4.98% |
| 2020 Q1 | 18.2 Million USD | 18.32% |
| 2020 FY | 83.81 Million USD | 29.19% |
| 2020 Q4 | 24.12 Million USD | -0.21% |
| 2019 Q1 | 8.47 Million USD | 0.0% |
| 2019 FY | 64.87 Million USD | 100.19% |
| 2019 Q4 | 15.38 Million USD | -46.65% |
| 2019 Q3 | 28.84 Million USD | 136.92% |
| 2019 Q2 | 12.17 Million USD | 43.73% |
| 2018 FY | 32.4 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cerus Corporation | 143.15 Million USD | 92.16% |
| OrthoPediatrics Corp. | 137.01 Million USD | 91.808% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 1.205% |
| Talis Biomedical Corporation | 67.18 Million USD | 83.294% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 55.007% |
| Inogen, Inc. | 236.08 Million USD | 95.246% |
| Spectral AI, Inc. | 20.86 Million USD | 46.204% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 79.956% |
| CVRx, Inc. | 76.14 Million USD | 85.259% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -218.141% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 10.129% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.318% |
| Venus Concept Inc. | 80.47 Million USD | 86.053% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 80.162% |
| Bioventus Inc. | 409.91 Million USD | 97.262% |
| BrainsWay Ltd. | 28.01 Million USD | 59.94% |
| Envoy Medical, Inc. | 17.89 Million USD | 37.289% |
| electroCore, Inc. | 32.03 Million USD | 64.959% |
| IceCure Medical Ltd | 16.87 Million USD | 33.491% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 73.548% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 36.347% |
| MaxCyte, Inc. | 84.84 Million USD | 86.771% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 9.57% |
| Nexalin Technology, Inc. | 5.78 Million USD | -94.141% |
| PAVmed Inc | 64.82 Million USD | 82.686% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 78.026% |
| RxSight, Inc. | 103.85 Million USD | 89.192% |
| Sight Sciences, Inc. | 126.44 Million USD | 91.124% |
| SI-BONE, Inc. | 156.35 Million USD | 92.821% |
| TELA Bio, Inc. | 84.18 Million USD | 86.668% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 83.979% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 94.481% |
| LivaNova PLC | 843.54 Million USD | 98.669% |
| 908 Devices Inc. | 68.08 Million USD | 83.514% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.679% |
| Nemaura Medical Inc. | 7.13 Million USD | -57.225% |
| NeuroPace, Inc. | 75.29 Million USD | 85.093% |
| LENSAR, Inc. | 33.33 Million USD | 66.331% |
| Apyx Medical Corporation | 51.01 Million USD | 78.0% |
| Cutera, Inc. | 197.72 Million USD | 94.323% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 54.707% |
| BioSig Technologies, Inc. | 28.53 Million USD | 60.659% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 94.138% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 68.874% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.658% |
| Axonics, Inc. | 270.2 Million USD | 95.846% |
| Outset Medical, Inc. | 198.77 Million USD | 94.353% |
| IRIDEX Corporation | 31.81 Million USD | 64.72% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 93.772% |
| IRadimed Corporation | 30.12 Million USD | 62.739% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -31.552% |
| INVO Bioscience, Inc. | 7.85 Million USD | -42.921% |
| Telesis Bio, Inc. | 63.48 Million USD | 82.321% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 88.6% |
| Varex Imaging Corporation | 224.8 Million USD | 95.007% |
| Quipt Home Medical Corp. | 148.66 Million USD | 92.45% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 4.257% |
| Pulmonx Corporation | 112.68 Million USD | 90.04% |
| Dynatronics Corporation | 9.9 Million USD | -13.282% |
| Modular Medical, Inc. | 17.52 Million USD | 35.969% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 44.4% |
| Semler Scientific, Inc. | 38.94 Million USD | 71.179% |
| InMode Ltd. | 215.68 Million USD | 94.796% |
| Bruker Corporation | 1.07 Billion USD | 98.957% |
| Cytosorbents Corporation | 48.33 Million USD | 76.78% |
| DexCom, Inc. | 1.69 Billion USD | 99.336% |
| Align Technology, Inc. | 2.07 Billion USD | 99.46% |
| Viveve Medical, Inc. | 22.17 Million USD | 49.38% |
| ZimVie Inc. | 275.12 Million USD | 95.92% |
| Movano Inc. | 29.69 Million USD | 62.196% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 91.823% |
| Nexalin Technology, Inc. | 5.78 Million USD | -94.141% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -218.141% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.132% |
| Profound Medical Corp. | 33.6 Million USD | 66.598% |
| Insulet Corporation | 939.9 Million USD | 98.806% |
| enVVeno Medical Corporation | 25.23 Million USD | 55.527% |
| Surmodics, Inc. | 98.69 Million USD | 88.628% |
| iCAD, Inc. | 22.22 Million USD | 49.498% |
| Nuwellis, Inc. | 22.61 Million USD | 50.365% |
| Biotricity, Inc. | 17.18 Million USD | 34.686% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.483% |
| Aethlon Medical, Inc. | 12.27 Million USD | 8.581% |
| InspireMD, Inc. | 22.95 Million USD | 51.094% |
| PAVmed Inc. | 64.82 Million USD | 82.686% |
| BIOLASE, Inc. | 34.66 Million USD | 67.618% |
| Beyond Air, Inc. | 61.7 Million USD | 81.809% |
| FONAR Corporation | 28.6 Million USD | 60.762% |
| AxoGen, Inc. | 149.33 Million USD | 92.484% |
| Vivani Medical, Inc. | 26.96 Million USD | 58.376% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 93.662% |
| Inari Medical, Inc. | 448.59 Million USD | 97.498% |
| UFP Technologies, Inc. | 58.08 Million USD | 80.678% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -127.778% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -77.643% |
| Tenon Medical, Inc. | 16.96 Million USD | 33.852% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -51.819% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 74.55% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.959% |
| Sintx Technologies, Inc. | 15.2 Million USD | 26.163% |
| NanoVibronix, Inc. | 4.97 Million USD | -125.699% |
| Quanterix Corporation | 118.1 Million USD | 90.496% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 4.257% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 22.282% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 97.142% |
| TransMedics Group, Inc. | 182.82 Million USD | 93.861% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 60.007% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1.127% |
| Hyperfine, Inc. | 52.87 Million USD | 78.771% |
| Establishment Labs Holdings Inc. | 172 Million USD | 93.475% |
| Biomerica, Inc. | 6.97 Million USD | -60.848% |
| Bone Biologics Corporation | 9.42 Million USD | -19.046% |
| AVITA Medical, Inc. | 80.77 Million USD | 86.105% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -8.852% |
| Silk Road Medical, Inc | 186.35 Million USD | 93.977% |